GSK2245035, CAS 1207629-49-9

Formulation: A solid

Formal Name: 6-amino-7,9-dihydro-2-[(1S)-1-methylbutoxy]-9-[5-(1-piperidinyl)pentyl]-8H-purin-8-one

Purity: ≥98%

Formula Markup: C20H34N6O2

Formula Weight: 390,5

Shelf life (days): 1460

CAS Number: 1207629-49-9

Notes: GSK2245035 is a toll-like receptor 7 (TLR7) agonist.{61357} It selectively induces the production of IFN-α over TNF-α in isolated human peripheral blood mononuclear cells (PBMCs; EC50s = 0.63 and 316 nM, respectively), as well as over the production of TNF-α, IL-1β, IFN-γ, IL-10, and IL-12p70 in isolated human whole blood (EC50s = 63-10,000 nM). GSK2245035 (0.1-1,000 nM) reduces timothy grass- or house dust mite-induced IL-10 and IL-5 release in isolated human PBMCs. Intranasal administration of GSK2245035 (0.03-1 mg/kg) increases serum IP-10 levels, a marker of IFN-α induction, in mice. It also increases serum levels of IP-10 in cynomolgus monkeys.

• Artikelnummer: CAY33171-1
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 33171-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK